Opioid-induced hyperalgesia: Cellular and molecular mechanisms

Area of Science:

• Neuroscience
• Pharmacology
• Pain Research

Background:

• Opioids provide analgesia but can cause opioid-induced hyperalgesia (OIH), a paradoxical increase in pain sensitivity.
• OIH is often linked to the development of analgesic tolerance, complicating pain management.
• Numerous preclinical studies have investigated OIH's modulating factors and underlying mechanisms.

Purpose of the Study:

• To review the cellular and molecular mechanisms contributing to opioid-induced hyperalgesia (OIH).
• To summarize intracellular and intercellular pathways involved in OIH development.
• To identify potential mechanisms for future therapeutic interventions against OIH.

Main Methods:

• Review of preclinical studies on opioid-induced hyperalgesia (OIH).
• Analysis of factors influencing OIH, including genetics, sex differences, and opioid regimens.
• Examination of cellular (neuronal and glial) and molecular pathways implicated in OIH.

Main Results:

• OIH development is influenced by genetic background, sex, and opioid regimen.
• Mu opioid receptor (MOR) variants and protein interactions are critical.
• Both neuronal processes (neuroexcitation, LTP, descending facilitation) and neuroinflammation (microglia, astrocytes) contribute synergistically to OIH.

Conclusions:

• Neuronal and glial cells play synergistic roles in OIH through complex intracellular and intercellular pathways.
• Molecular actors like Toll-like receptor 4 and anti-opioid systems are involved.
• Understanding these pathways offers targets for developing strategies to limit OIH and improve opioid therapy.